Based on the previous literature and given the detectable levels of SPARC in conditioned medium of fibroblasts, we can hypothesize that the source of circulating SPARC in our patients is from stromal fibroblasts, rather than from cancer cells, and that protein levels in plasma could reflect changes in a microenvironment that becomes activated and permissive to tumor growth and progression. Here, SPARC is linked to neoplasm.